By Counterforce Health Team in Ofev (nintedanib) —

How to Get Ofev (Nintedanib) Covered by Cigna in California: Requirements, Appeals, and Success Strategies

Quick Answer: Getting Ofev (Nintedanib) Covered by Cigna in California

Eligibility: Ofev requires prior authorization from Cigna for idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated ILD (SSc-ILD). Fastest path: Have your pulmonologist submit a complete PA with HRCT results, PFTs showing FVC ≥40%, and medical necessity letter. First step today: Contact your pulmonologist's office to confirm they have your latest imaging and lung function tests, then request they initiate the PA process through Cigna's provider portal. If denied, California's Independent Medical Review (IMR) offers a binding external appeal within 30 days.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria for Coverage
  4. Documentation Requirements
  5. Submission Process
  6. Specialty Pharmacy Routing
  7. After Submission: What to Expect
  8. Common Denial Reasons & Solutions
  9. Appeals Process in California
  10. Cost Assistance Programs
  11. Frequently Asked Questions
  12. Quick Reference Checklist

Who Should Use This Guide

This guide is designed for California residents with Cigna insurance who need Ofev (nintedanib) for:

  • Idiopathic pulmonary fibrosis (IPF)
  • Systemic sclerosis-associated interstitial lung disease (SSc-ILD)
  • Chronic fibrosing interstitial lung diseases with progressive phenotype

Expected outcome: Following this guide increases your chances of first-time approval and provides a clear roadmap if you face a denial. Ofev typically costs $13,000-$15,000 per month without insurance coverage.

Member & Plan Basics

Coverage Requirements

  • Active Cigna coverage with prescription drug benefits
  • Prior authorization required for all Ofev prescriptions
  • Specialty pharmacy routing through Express Scripts/Accredo typically required
  • No step therapy required for IPF, but SSc-ILD may require prior mycophenolate trial

Plan Types Covered

  • Commercial Cigna plans
  • Cigna Medicare Advantage (different PA form may apply)
  • Cigna Medicaid (varies by state contract)
Note: Verify your specific plan's formulary status at Cigna's formulary lookup tool.

Clinical Criteria for Coverage

Coverage at a Glance

Requirement IPF SSc-ILD Where to Find
Age 18+ years 18+ years Patient record
Diagnosis confirmation HRCT showing UIP pattern OR surgical lung biopsy HRCT showing ≥10% fibrosis Radiology report
Pulmonary function FVC ≥40% predicted FVC ≥40%, DLco ≥30% predicted Recent PFTs
Prescriber Pulmonologist required Pulmonologist required Provider credentials
Prior therapy None required Mycophenolate trial often required Medical records

Source: Cigna Policy CNF_416

Key Clinical Requirements

For IPF:

  1. Diagnosis confirmed by:
    • High-resolution CT showing usual interstitial pneumonia (UIP) pattern, OR
    • Surgical lung biopsy demonstrating UIP
  2. Forced vital capacity (FVC) ≥40% of predicted value
  3. Prescribed by or in consultation with a pulmonologist
  4. No concurrent use of pirfenidone (Esbriet)

For SSc-ILD:

  1. Systemic sclerosis diagnosis with associated ILD
  2. HRCT showing pulmonary fibrosis involving ≥10% of lungs
  3. FVC ≥40% and DLco ≥30% of predicted
  4. Prior mycophenolate trial (or documented contraindication)

Documentation Requirements

Medical Necessity Letter Components

Your pulmonologist's letter must include:

Essential Elements:

  • Patient demographics and insurance information
  • Specific diagnosis with ICD-10 codes (J84.10 for IPF, M34.81 for SSc-ILD)
  • HRCT findings with radiologist interpretation
  • Current pulmonary function test results
  • Prior treatment history and rationale for Ofev
  • Monitoring plan for liver function tests

Supporting Documents:

  • Recent HRCT report (within 6 months)
  • Pulmonary function tests showing baseline values
  • Consultation notes from pulmonologist
  • Lab results excluding other causes of ILD
  • Insurance card copy
Clinician Corner: Use Boehringer Ingelheim's medical necessity letter templates as a starting point, but customize for your patient's specific clinical scenario.

Submission Process

Step-by-Step: Fastest Path to Approval

  1. Gather Documentation (Patient + Clinic)
    • Collect insurance card, recent HRCT, PFTs, and specialist notes
    • Timeline: 1-2 business days
  2. Complete PA Form (Pulmonologist)
    • Submit via Cigna provider portal or CoverMyMeds
    • Include all required attachments
    • Timeline: Same day if documents ready
  3. Cigna Review (Automated)
    • Initial review for completeness
    • Timeline: 3-5 business days for standard review
  4. Clinical Review (If needed)
    • Medical director or peer review
    • Timeline: Additional 5-10 business days
  5. Approval/Denial Notice (Cigna to Patient + Provider)
    • Written determination required
    • Timeline: Within 15 days total for non-urgent requests

Expedited Process: For urgent clinical situations, request expedited review (72-hour turnaround).

Specialty Pharmacy Routing

Express Scripts/Accredo Enrollment

Once approved, Ofev typically requires specialty pharmacy dispensing:

Enrollment Steps:

  1. Provider initiates referral to Accredo Specialty Pharmacy
  2. Patient enrollment via phone: (844) 708-0093
  3. Insurance verification and copay calculation
  4. First shipment coordination (temperature-controlled delivery)

Transfer from Another Pharmacy:

  • Remaining refills transfer automatically to Accredo
  • New prescription required if no refills remain
  • Contact current pharmacy to initiate transfer

Source: Boehringer Ingelheim Fulfillment Overview

After Submission: What to Expect

Tracking Your Request

Confirmation Numbers: Save all reference numbers from Cigna and your provider Status Checks:

  • Cigna member portal updates every 24-48 hours
  • Provider can check via Cigna provider portal
  • Call member services: 1-800-Cigna24

Timeline Expectations:

  • Standard PA: 15 calendar days maximum
  • Expedited PA: 72 hours maximum
  • Appeal (internal): 30 days
  • External review (IMR): 30 days in California

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
"Specialist attestation missing" Pulmonologist must be primary prescriber Board certification verification
"HRCT findings insufficient" Submit complete radiology report with UIP/fibrosis quantification Full HRCT report with measurements
"PFT values don't meet criteria" Ensure FVC ≥40% clearly documented Recent PFT report with predicted values
"Prior therapy not documented" For SSc-ILD, show mycophenolate trial/contraindication Treatment history with dates/outcomes
"Not medically necessary" Strengthen clinical rationale with guidelines ATS/ERS guidelines, FDA labeling

Appeals Process in California

Internal Appeals with Cigna

First-Level Appeal:

  • Deadline: 180 days from denial date
  • Method: Cigna member portal, phone, or written request
  • Timeline: 30 days for standard, 72 hours for expedited
  • Required: Copy of denial letter, additional clinical information

Second-Level Appeal:

  • Automatic: If first appeal denied
  • Timeline: Additional 30 days
  • Peer-to-Peer: Request physician-to-physician review

California Independent Medical Review (IMR)

If Cigna upholds the denial, California residents can request binding external review:

Eligibility:

  • Denial based on medical necessity, experimental/investigational determination, or emergency services dispute
  • Must complete Cigna's internal appeal process first

Process:

  1. File IMR application within 30 days of final internal denial
  2. Submit through DMHC (for HMO plans) or CDI (for PPO plans)
  3. Independent physician review by specialty expert
  4. Binding decision within 30 days (expedited: 72 hours)

Success Rate: California IMR overturns approximately 12.7% of denials, with higher success rates for well-documented rare disease cases.

How to File:

  • DMHC Help Center: (888) 466-2219
  • Online application: healthhelp.ca.gov
  • No cost to patient

Source: California Department of Managed Health Care

Cost Assistance Programs

Manufacturer Support

Boehringer Ingelheim OPEN DOORS Program:

  • Copay assistance for commercially insured patients
  • Patient assistance for uninsured/underinsured
  • Bridge therapy during PA review
  • Phone: 1-844-OPEN-4-ME (1-844-673-6463)

Additional Resources

Frequently Asked Questions

Q: How long does Cigna prior authorization take for Ofev? A: Standard requests: up to 15 days. Expedited requests (for urgent clinical situations): 72 hours. Most approvals come within 5-7 business days if documentation is complete.

Q: What if Ofev isn't on Cigna's formulary? A: Request a formulary exception through your doctor. Provide clinical rationale for why covered alternatives aren't appropriate for your specific condition.

Q: Can I get temporary supply while PA is pending? A: Yes, Boehringer Ingelheim's Bridge Program may provide up to 15 days of medication during PA review. Contact OPEN DOORS at 1-844-673-6463.

Q: Does step therapy apply to Ofev in California? A: For IPF, typically no step therapy required. For SSc-ILD, many Cigna policies require prior mycophenolate trial or documented contraindication.

Q: What happens if I move from California to another state? A: Appeal rights and external review processes vary by state. Contact your new state's insurance department for specific procedures.

Q: Can my primary care doctor prescribe Ofev? A: Cigna requires prescription by or in consultation with a board-certified pulmonologist for coverage approval.

Quick Reference Checklist

Before Starting:

  • Confirm active Cigna prescription coverage
  • Verify pulmonologist is in-network
  • Gather recent HRCT report (within 6 months)
  • Obtain current pulmonary function tests
  • Document prior treatments and outcomes

For PA Submission:

  • Complete Cigna PA form
  • Medical necessity letter from pulmonologist
  • HRCT report with UIP/fibrosis findings
  • PFT results showing FVC ≥40%
  • Insurance card copy
  • ICD-10 diagnosis codes included

If Denied:

  • File internal appeal within 180 days
  • Request peer-to-peer review
  • Prepare for California IMR if needed
  • Contact OPEN DOORS for bridge therapy

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to create point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and operational details that insurers expect for complex medications like Ofev.

From Our Advocates: "We've seen Cigna approvals improve significantly when the initial PA includes quantified HRCT findings—not just 'consistent with UIP' but specific measurements like 'honeycombing involving 15% of lung bases.' The more precise your documentation, the stronger your case." This represents a composite of successful strategies, not guaranteed outcomes.

If you're facing challenges with your Ofev coverage, remember that Counterforce Health specializes in transforming complex denials into successful appeals by leveraging payer-specific workflows and evidence requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and clinical circumstances. Always consult with your healthcare provider and insurance company for personalized guidance. For assistance with appeals or coverage issues, contact the California Department of Managed Health Care Help Center at (888) 466-2219.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.